<DOC>
	<DOCNO>NCT02422082</DOCNO>
	<brief_summary>Lactobacillus reuteri ( L. reuteri ) widely study clinical trial probiotic , health-promoting effect adult child , safe human consumption . Animal model indicate treatment L. reuteri positive effect bone metabolism bone density . In animal model diabetes metabolic syndrome , positive effect blood glucose weight report . The present double-blind , placebo-controlled , randomize study design investigate dietary supplementation L. reuteri twice daily 12 month effect bone density , body composition , inflammation , metabolic endocrine marker elderly woman osteopenia .</brief_summary>
	<brief_title>The Effect Lactobacillus Reuteri ATCC PTA 6475 Volumetric Bone Mineral Density Patients With Osteopenia</brief_title>
	<detailed_description>The role gut microbe human health gain considerable interest recent year . Lactobacillus reuteri ( L.reuteri ) naturally occur bacterial specie human gut . L. reuteri widely study clinical trial adult child treatment L. reuteri safe associate health-promoting effect human . In animal model , L. reuteri anti-inflammatory effect ovariectomized mice supplementation L. reuteri partly prevent bone loss induce estrogen deficiency . Furthermore , bone density bone formation increase male mouse another mouse model . In mouse medically induced diabetes mellitus , L. reuteri reduce blood glucose mouse model mimic metabolic syndrome , L. reuteri prevent diet-induced obesity . The present study double-blind , placebo-controlled , randomize , study 90 elderly woman osteopenia recruit population . These woman treat L. reuteri placebo orally twice daily 12 month . The effect bone investigate dual energy x-ray absorptiometry , high-resolution peripheral quantitative compute tomography , bone turnover marker . Hormones marker inflammation metabolism follow well change gut microbiota composition .</detailed_description>
	<mesh_term>Bone Diseases , Metabolic</mesh_term>
	<criteria>bone mineral density Tscore less 1 2.5 total hip lumbar spine ( L1L4 ) dual energy xray absorptiometry sign informed consent state availability throughout entire study period mental ability understand willingness fulfill detail protocol untreated hyperthyroidism rheumatoid arthritis diagnose disease cause secondary osteoporosis within last year , include primary hyperparathyroidism , chronic obstructive pulmonary disease , inflammatory bowel disease , celiac disease , diabetes recently diagnose malignancy ( within last 5 year ) per oral corticosteroid use use antiresorptive therapy , include systemic hormone replacement therapy , bisphosphonates , strontium run elate use teriparatide ( current last 3 year ) participation clinical interventional trial use antibiotic within 2 month precede inclusion</criteria>
	<gender>Female</gender>
	<minimum_age>75 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Osteopenia</keyword>
	<keyword>Lactobacillus reuteri</keyword>
	<keyword>Volumetric bone mineral density</keyword>
</DOC>